Paper

Long-term Benefits of Mirikizumab on Patient-Reported Outcomes in Individuals with Crohn's Disease: 2-Year Results from the VIVID-2 Extension Study

Clinical and Translational Gastroenterology · 2026 · Minhu Chen, Ailsa Hart, Aisha Vadhariya et al.